Erratum: Difficulties in ensuring review quality performed by committees under the Act on the Safety of Regenerative Medicine in Japan (Stem Cell Reports (2023) 18(3) (613–617), (S2213671123000164), (10.1016/j.stemcr.2023.01.013))

Tsunakuni Ikka; Misao Fujita; Taichi Hatta; Tetsu Isobe; Kenji Konomi; Tatsuo Onishi; Shoji Sanada; Yuichiro Sato; Shimon Tashiro; Morikuni Tobita

doi:10.1016/j.stemcr.2023.04.006

Erratum: Difficulties in ensuring review quality performed by committees under the Act on the Safety of Regenerative Medicine in Japan (Stem Cell Reports (2023) 18(3) (613–617), (S2213671123000164), (10.1016/j.stemcr.2023.01.013))

Tsunakuni Ikka
, Misao Fujita
, Taichi Hatta
, Tetsu Isobe
, Kenji Konomi
, Tatsuo Onishi
, Shoji Sanada
, Yuichiro Sato
, Shimon Tashiro
, Morikuni Tobita

研究成果: Comment/debate › 査読

2 被引用数 (Scopus)

抄録

(Stem Cell Reports 18, 613–617; March 14, 2023) The authors have changed all references to “Whitelist” in the supplemental information to the term “DOAJ or Web of Science.” The reason for the change was to use a more socially fair and neutral term that does not contain discriminatory meanings or misinterpretations.

本文言語	English
ページ（範囲）	1247
ページ数	1
ジャーナル	Stem cell reports
巻	18
号	5
DOI	https://doi.org/10.1016/j.stemcr.2023.04.006
出版ステータス	Published - 2023 5月 9

ASJC Scopus subject areas

生化学
遺伝学
発生生物学
細胞生物学

文献へのアクセス

10.1016/j.stemcr.2023.04.006

他のファイルとリンク

フィンガープリント

「Erratum: Difficulties in ensuring review quality performed by committees under the Act on the Safety of Regenerative Medicine in Japan (Stem Cell Reports (2023) 18(3) (613–617), (S2213671123000164), (10.1016/j.stemcr.2023.01.013))」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル

Ikka, T., Fujita, M., Hatta, T., Isobe, T., Konomi, K., Onishi, T., Sanada, S., Sato, Y., Tashiro, S., & Tobita, M. (2023). Erratum: Difficulties in ensuring review quality performed by committees under the Act on the Safety of Regenerative Medicine in Japan (Stem Cell Reports (2023) 18(3) (613–617), (S2213671123000164), (10.1016/j.stemcr.2023.01.013)). Stem cell reports, 18(5), 1247. https://doi.org/10.1016/j.stemcr.2023.04.006

Erratum: Difficulties in ensuring review quality performed by committees under the Act on the Safety of Regenerative Medicine in Japan (Stem Cell Reports (2023) 18(3) (613–617), (S2213671123000164), (10.1016/j.stemcr.2023.01.013)). / Ikka, Tsunakuni; Fujita, Misao; Hatta, Taichi その他.
In: Stem cell reports, Vol. 18, No. 5, 09.05.2023, p. 1247.

研究成果: Comment/debate › 査読

Ikka, T, Fujita, M, Hatta, T, Isobe, T , Konomi, K, Onishi, T, Sanada, S, Sato, Y, Tashiro, S & Tobita, M 2023, 'Erratum: Difficulties in ensuring review quality performed by committees under the Act on the Safety of Regenerative Medicine in Japan (Stem Cell Reports (2023) 18(3) (613–617), (S2213671123000164), (10.1016/j.stemcr.2023.01.013))', Stem cell reports, vol. 18, no. 5, pp. 1247. https://doi.org/10.1016/j.stemcr.2023.04.006

Ikka T, Fujita M, Hatta T, Isobe T , Konomi K, Onishi T その他. Erratum: Difficulties in ensuring review quality performed by committees under the Act on the Safety of Regenerative Medicine in Japan (Stem Cell Reports (2023) 18(3) (613–617), (S2213671123000164), (10.1016/j.stemcr.2023.01.013)). Stem cell reports. 2023 5月 9;18(5):1247. doi: 10.1016/j.stemcr.2023.04.006

@article{0478bb98138648dcb8a84aa981d62a40,

title = "Erratum: Difficulties in ensuring review quality performed by committees under the Act on the Safety of Regenerative Medicine in Japan (Stem Cell Reports (2023) 18(3) (613–617), (S2213671123000164), (10.1016/j.stemcr.2023.01.013))",

abstract = "(Stem Cell Reports 18, 613–617; March 14, 2023) The authors have changed all references to “Whitelist” in the supplemental information to the term “DOAJ or Web of Science.” The reason for the change was to use a more socially fair and neutral term that does not contain discriminatory meanings or misinterpretations.",

author = "Tsunakuni Ikka and Misao Fujita and Taichi Hatta and Tetsu Isobe and Kenji Konomi and Tatsuo Onishi and Shoji Sanada and Yuichiro Sato and Shimon Tashiro and Morikuni Tobita",

note = "Publisher Copyright: {\textcopyright} 2023 The Author(s)",

year = "2023",

month = may,

day = "9",

doi = "10.1016/j.stemcr.2023.04.006",

language = "English",

volume = "18",

pages = "1247",

journal = "Stem cell reports",

issn = "2213-6711",

publisher = "Cell Press",

number = "5",

}

TY - JOUR

T1 - Erratum

T2 - Difficulties in ensuring review quality performed by committees under the Act on the Safety of Regenerative Medicine in Japan (Stem Cell Reports (2023) 18(3) (613–617), (S2213671123000164), (10.1016/j.stemcr.2023.01.013))

AU - Ikka, Tsunakuni

AU - Fujita, Misao

AU - Hatta, Taichi

AU - Isobe, Tetsu

AU - Konomi, Kenji

AU - Onishi, Tatsuo

AU - Sanada, Shoji

AU - Sato, Yuichiro

AU - Tashiro, Shimon

AU - Tobita, Morikuni

PY - 2023/5/9

Y1 - 2023/5/9

N2 - (Stem Cell Reports 18, 613–617; March 14, 2023) The authors have changed all references to “Whitelist” in the supplemental information to the term “DOAJ or Web of Science.” The reason for the change was to use a more socially fair and neutral term that does not contain discriminatory meanings or misinterpretations.

AB - (Stem Cell Reports 18, 613–617; March 14, 2023) The authors have changed all references to “Whitelist” in the supplemental information to the term “DOAJ or Web of Science.” The reason for the change was to use a more socially fair and neutral term that does not contain discriminatory meanings or misinterpretations.

UR - https://www.scopus.com/pages/publications/85156211548

UR - https://www.scopus.com/pages/publications/85156211548#tab=citedBy

U2 - 10.1016/j.stemcr.2023.04.006

DO - 10.1016/j.stemcr.2023.04.006

M3 - Comment/debate

C2 - 37163983

AN - SCOPUS:85156211548

SN - 2213-6711

VL - 18

SP - 1247

JO - Stem cell reports

JF - Stem cell reports

IS - 5

ER -